טוען...
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort
BACKGROUND: IEtravirine (ETR) was approved in France in Sept 2008, to be used in combination with a ritonavir-boosted protease inhibitor (bPI) and others antiretrovirals (ARV) in HIV-infected pre-treated patients. OBJECTIVES: To describe in a real life setting efficacy and tolerability of ETR-includ...
שמור ב:
| הוצא לאור ב: | J Int AIDS Soc |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
International AIDS Society
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225285/ https://ncbi.nlm.nih.gov/pubmed/25397524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19780 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|